ARL2BP: A Potential Drug Target and Biomarker (G23568)

Target Name: ARL2BP

NCBI ID: G23568

ARL2BP

ARL2BP: A Potential Drug Target and Biomarker

ARL2BP (Aryl2-binding protein) is a protein that is expressed in various tissues of the human body. It is a key regulator of cell proliferation and has been implicated in the development and progression of various diseases, including cancer. The identification of potential drug targets and biomarkers for ARL2BP has significant implications for the development of new treatments for these diseases.

Potential Drug Targets

ARL2BP has been identified as a potential drug target due to its involvement in cell proliferation and its role in the regulation of the Notch signaling pathway. The Notch signaling pathway is a critical pathway that regulates cell proliferation, survival, and differentiation, and is implicated in the development and progression of various diseases, including cancer.

ARL2BP has been shown to play a role in the regulation of Notch signaling by binding to the protein Notch-1, which is a key component of the Notch signaling pathway. The binding of ARL2BP to Notch-1 has been shown to inhibit the activity of Notch-1 and reduce the level of Notch-1-mediated signaling.

In addition to its role in Notch signaling, ARL2BP has also been shown to be involved in the regulation of cell adhesion and migration. These processes are critical for the development and progression of various diseases, including cancer.

Potential Biomarkers

The identification of potential biomarkers for ARL2BP has significant implications for the development of new diagnostic tests and treatments for various diseases.

ARL2BP has been shown to be involved in the regulation of cell cycle progression, which is a critical process for the development and progression of cancer. The regulation of cell cycle progression is a critical pathway that is regulated by numerous factors, including ARL2BP.

In addition to its role in cell cycle progression, ARL2BP has also been shown to be involved in the regulation of apoptosis, which is a critical process for the elimination of damaged or dysfunctional cells. The regulation of apoptosis is a critical pathway that is regulated by numerous factors, including ARL2BP.

Conclusion

In conclusion, ARL2BP is a protein that has significant implications for the development of new treatments for various diseases due to its involvement in cell proliferation and the regulation of Notch signaling pathway. The identification of potential drug targets and biomarkers for ARL2BP has significant implications for the development of new treatments for these diseases. Further research is needed to fully understand the role of ARL2BP in the regulation of cell proliferation and the development and progression of various diseases.

Protein Name: ADP Ribosylation Factor Like GTPase 2 Binding Protein

Functions: Together with ARL2, plays a role in the nuclear translocation, retention and transcriptional activity of STAT3. May play a role as an effector of ARL2

The "ARL2BP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARL2BP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets